Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Our competion?

byergo,

I agree completely re GNBT. Certainly not investible and possibly fraudulent.

http://www.thestreet.com/story/10718111/1/generex-what-happens-in-india-stays-in-india.html?cm_ven=GOOGLEN

But I keep open to the idea of buccal / sublingual insulin as a competative threat somewhere down the road. Personally, I think MNKD has this beat hands down and it is light years ahead. So odds are we have no competition for at least 5 years. But never say never. There was a time when anything but injectable insulin was ludicrous...

Share
New Message
Please login to post a reply